Assessment of sestrin 2 as a sepsis marker and predictor of disease severity

Introduction Sestrin 2 is considered a stress-inducible antioxidant protein. This study was aimed to evaluate sestrin 2 in subjects with sepsis, and its correlation with clinical severity and mortality.Methods Sepsis and control group patients were followed from admission to discharge. A blood sampl...

Full description

Saved in:
Bibliographic Details
Main Authors: Osman Baspınar, Derya Kocer, Kaniye Aydın, Oguzhan Sıtkı Dizdar
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:The Aging Male
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/13685538.2024.2424300
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850180037642289152
author Osman Baspınar
Derya Kocer
Kaniye Aydın
Oguzhan Sıtkı Dizdar
author_facet Osman Baspınar
Derya Kocer
Kaniye Aydın
Oguzhan Sıtkı Dizdar
author_sort Osman Baspınar
collection DOAJ
description Introduction Sestrin 2 is considered a stress-inducible antioxidant protein. This study was aimed to evaluate sestrin 2 in subjects with sepsis, and its correlation with clinical severity and mortality.Methods Sepsis and control group patients were followed from admission to discharge. A blood sample was taken at admission for determination of serum sestrin 2 level.Results Of the total 42 patients with sepsis, there were 25 females and the mean age was 74.9 years. The sestrin 2 levels were significantly higher in the sepsis group. The optimum sestrin 2 cut-off point of ≥3.13 ng/mL had 95.2% sensitivity and 71.4% specificity for sepsis (p < .001). Sestrin 2 levels were higher in patients who needed renal replacement therapy (p = .018), patients who needed vasopressor therapy (p = .001) and patients with organ dysfunction (p = .002). The sestrin 2 level was significantly correlated with Acute Physiology and Chronic Health Evaluation (APACHE) II score, Nutrition Risk in the Critically Ill (NUTRIC) Score, C-reactive protein and albumin. Sestrin 2 levels were not associated with 30 d mortality in sepsis patients.Conclusions Sestrin 2 was significantly higher in the sepsis patients and associated with sepsis related adverse clinical outcomes. These results provided information concerning the clinical utility of sestrin 2.
format Article
id doaj-art-3c1c3704b35c4ed0ba31e6fa86f20e2b
institution OA Journals
issn 1368-5538
1473-0790
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series The Aging Male
spelling doaj-art-3c1c3704b35c4ed0ba31e6fa86f20e2b2025-08-20T02:18:20ZengTaylor & Francis GroupThe Aging Male1368-55381473-07902024-12-0127110.1080/13685538.2024.2424300Assessment of sestrin 2 as a sepsis marker and predictor of disease severityOsman Baspınar0Derya Kocer1Kaniye Aydın2Oguzhan Sıtkı Dizdar3Department of Internal Medicine, Kayseri City Training and Research Hospital, Kayseri, TurkeyDepartment of Biochemistry, Kayseri City Training and Research Hospital, Kayseri, TurkeyDepartment of Internal Medicine Division of Intensive Care, Kayseri City Training and Research Hospital, Kayseri, TurkeyDepartment of Internal Medicine and Clinical Nutrition Unit, Kayseri City Training and Research Hospital University of Health Sciences, Kayseri, TurkeyIntroduction Sestrin 2 is considered a stress-inducible antioxidant protein. This study was aimed to evaluate sestrin 2 in subjects with sepsis, and its correlation with clinical severity and mortality.Methods Sepsis and control group patients were followed from admission to discharge. A blood sample was taken at admission for determination of serum sestrin 2 level.Results Of the total 42 patients with sepsis, there were 25 females and the mean age was 74.9 years. The sestrin 2 levels were significantly higher in the sepsis group. The optimum sestrin 2 cut-off point of ≥3.13 ng/mL had 95.2% sensitivity and 71.4% specificity for sepsis (p < .001). Sestrin 2 levels were higher in patients who needed renal replacement therapy (p = .018), patients who needed vasopressor therapy (p = .001) and patients with organ dysfunction (p = .002). The sestrin 2 level was significantly correlated with Acute Physiology and Chronic Health Evaluation (APACHE) II score, Nutrition Risk in the Critically Ill (NUTRIC) Score, C-reactive protein and albumin. Sestrin 2 levels were not associated with 30 d mortality in sepsis patients.Conclusions Sestrin 2 was significantly higher in the sepsis patients and associated with sepsis related adverse clinical outcomes. These results provided information concerning the clinical utility of sestrin 2.https://www.tandfonline.com/doi/10.1080/13685538.2024.2424300Sepsissestrin 2intensive care unitprognosisC-reactive protein
spellingShingle Osman Baspınar
Derya Kocer
Kaniye Aydın
Oguzhan Sıtkı Dizdar
Assessment of sestrin 2 as a sepsis marker and predictor of disease severity
The Aging Male
Sepsis
sestrin 2
intensive care unit
prognosis
C-reactive protein
title Assessment of sestrin 2 as a sepsis marker and predictor of disease severity
title_full Assessment of sestrin 2 as a sepsis marker and predictor of disease severity
title_fullStr Assessment of sestrin 2 as a sepsis marker and predictor of disease severity
title_full_unstemmed Assessment of sestrin 2 as a sepsis marker and predictor of disease severity
title_short Assessment of sestrin 2 as a sepsis marker and predictor of disease severity
title_sort assessment of sestrin 2 as a sepsis marker and predictor of disease severity
topic Sepsis
sestrin 2
intensive care unit
prognosis
C-reactive protein
url https://www.tandfonline.com/doi/10.1080/13685538.2024.2424300
work_keys_str_mv AT osmanbaspınar assessmentofsestrin2asasepsismarkerandpredictorofdiseaseseverity
AT deryakocer assessmentofsestrin2asasepsismarkerandpredictorofdiseaseseverity
AT kaniyeaydın assessmentofsestrin2asasepsismarkerandpredictorofdiseaseseverity
AT oguzhansıtkıdizdar assessmentofsestrin2asasepsismarkerandpredictorofdiseaseseverity